Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy President & CEO bought 4,226 shares at an average $8.15 ($34,435)
  2. 4 Open-market buy President & CEO bought 874 shares at $8.07 ($7,053)
  3. 4 Open-market buy President & CEO bought 13,400 shares at an average $7.50 ($100,475)
  4. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
  5. 4 Open-market buy CSO/CMO bought 1,315 shares at $7.60 ($9,994)
  6. 4/A Open-market buy Director bought 500 shares at $7.30 ($3,650)
  7. 4 Open-market buy Director bought 3,650 shares at $7.30 ($26,645)
  8. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $8.50 ($8,500)
  9. 4 Open-market buy Director bought 79,410 shares at $8.50 ($674,985)
  10. 4 Open-market buy President & CEO bought 23,529 shares at $8.50 ($199,997)
  11. 4 Open-market buy Director bought 5,000 shares at $8.50 ($42,500)
  12. 4 Open-market buy 10% owner bought 411,765 shares at $8.50 ($3,500,003)
  13. 4 Open-market buy 10% owner bought 308,824 shares at $8.50 ($2,625,004)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 19 · 364 filings